Loading...
Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
OBJECTIVE: In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group. However, it remains to be determined whether finasteride concentrations may affect prostate cancer risk....
Saved in:
| Published in: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Public Library of Science
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425512/ https://ncbi.nlm.nih.gov/pubmed/25955319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0126672 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|